Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
This study is ongoing, but not recruiting participants.
Study NCT00034307   Information provided by ICOS-Texas Biotechnology
First Received: April 24, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Hypertension
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
sitaxsentan sodium
Sponsors listed in this trial
ICOS-Texas Biotechnology
ICOS Corporation
Texas Biotechnology Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services